Idorsia Ltd (SIX: IDIA) announces the publication of results from the pivotal Phase 3 MODIFY study and its open-label extension (OLE) evaluating lucerastat, an oral substrate reduction therapy, in ...
Even when market forces eventually push prices down, the clock is rarely fully wound back and wages often fail to keep pace ...
Preparing for the CBSE Class 10 Science Board Exam 2026 requires focused practice and smart revision. One of the most ...